Search research articles
Contact Us
Filters
Showing results (801-810 of 1,158) with videos related to
Page
of 116
Sort By:
The American Journal of Cardiology
|
July 15, 1997
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease
B G Brown, J Bardsley, D Poulin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2017
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
Nicole S Goh, Rachel K Hoyles, Christopher P Denton, et al.
Respiration; International Review of Thoracic Diseases
|
April 12, 2017
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone
Michael Kreuter, Paolo Spagnolo, Wim Wuyts, et al.
Chest
|
April 10, 2026
Characterising cough and its response to therapy in hypersensitivity pneumonitis
Z Wu, L Yazbeck, D J F Smith, et al.
Respiratory Medicine
|
November 8, 2016
Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted
Katie Ward, Lydia Spurr, Nina R Goldman, et al.
The European Respiratory Journal
|
December 22, 2023
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis
Marlies Wijsenbeek, Jeffrey J Swigris, Yoshikazu Inoue, et al.
European Radiology
|
July 26, 2014
The utilisation and diagnostic yield of radiological imaging in a specialist functional GI disorder clinic: an 11-year retrospective study
Micheal Breen, Kevin P Murphy, Siobhan B O'Neill, et al.
The Lancet. Respiratory Medicine
|
September 20, 2017
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
Surinder S Birring, Marlies S Wijsenbeek, Sanjay Agrawal, et al.
World Journal of Radiology
|
May 10, 2016
Cumulative radiation exposure from diagnostic imaging in intensive care unit patients
Fiachra Moloney, Daniel Fama, Maria Twomey, et al.
ERJ Open Research
|
December 17, 2024
Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis
R Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka, et al.
Page
of 116
Search research articles
Search
Showing results (801-810 of 1,158) with videos related to
Sort By:
Page
of 116
The American Journal of Cardiology
|
July 15, 1997
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg/dl in patients with hyperlipidemia and coronary artery disease
B G Brown, J Bardsley, D Poulin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 21, 2017
Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
Nicole S Goh, Rachel K Hoyles, Christopher P Denton, et al.
Respiration; International Review of Thoracic Diseases
|
April 12, 2017
Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone
Michael Kreuter, Paolo Spagnolo, Wim Wuyts, et al.
Chest
|
April 10, 2026
Characterising cough and its response to therapy in hypersensitivity pneumonitis
Z Wu, L Yazbeck, D J F Smith, et al.
Respiratory Medicine
|
November 8, 2016
Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted
Katie Ward, Lydia Spurr, Nina R Goldman, et al.
The European Respiratory Journal
|
December 22, 2023
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis
Marlies Wijsenbeek, Jeffrey J Swigris, Yoshikazu Inoue, et al.
European Radiology
|
July 26, 2014
The utilisation and diagnostic yield of radiological imaging in a specialist functional GI disorder clinic: an 11-year retrospective study
Micheal Breen, Kevin P Murphy, Siobhan B O'Neill, et al.
The Lancet. Respiratory Medicine
|
September 20, 2017
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
Surinder S Birring, Marlies S Wijsenbeek, Sanjay Agrawal, et al.
World Journal of Radiology
|
May 10, 2016
Cumulative radiation exposure from diagnostic imaging in intensive care unit patients
Fiachra Moloney, Daniel Fama, Maria Twomey, et al.
ERJ Open Research
|
December 17, 2024
Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis
R Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka, et al.
Page
of 116